Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00510835 · ClinicalTrials.gov registry record · NA
Protocolized Care for Early Septic Shock
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 1,351
- Enrollment target
NCT00510835: Completed NA study, sponsored by University of Pittsburgh.
NCT00510835 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 1,351 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00510835, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,351 participants
- Enrollment target
Study Summary
The ProCESS study is large, 5-year, multicenter study of alternative resuscitation strategies for septic shock. The study hypothesizes that there are "golden hours" in the initial management of septic shock where prompt, rigorous, standardized care can improve clinical outcomes.
Primary Outcome
The primary study outcome is hospital mortality (defined as the number of deaths prior to discharge or 60 days, whichever comes first). The secondary outcomes are duration of survival (90 day and 1 year) and clinical evidence of organ dysfunction.
Interventions
- PROCEDURE Usual Care (UC)
- PROCEDURE Early Goal Directed Therapy (EGDT)
- PROCEDURE Protocolized Standard Care (PSC)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,351 participants |
| Start Date | 2008-03 |
| Est. Completion | 2013-12 |
| Phase | NA |
What the finished NCT00510835 record still lists
NCT00510835 is an interventional study that assigns participants to a tested intervention. Its 1,351 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which Usual Care (UC) is the first listed.
NCT00510835 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00510835 about?
NCT00510835 is a clinical study titled "Protocolized Care for Early Septic Shock". The ProCESS study is large, 5-year, multicenter study of alternative resuscitation strategies for septic shock. The study hypothesizes that there are "golden hours" in the initial management of septic shock where prompt, rigorous, standardized care can improve clinical outcomes.
What is the current status of trial NCT00510835?
This trial is currently completed. It is a NA study. The enrollment target is 1,351 participants. The study started on 2008-03. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00510835?
The interventions under investigation include: Usual Care (UC) (PROCEDURE), Early Goal Directed Therapy (EGDT) (PROCEDURE), Protocolized Standard Care (PSC) (PROCEDURE).
Who is sponsoring clinical trial NCT00510835?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00510835's enrollment target sits among peer trials
1,351 73rd of 2000 higher than 1,928 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
- NCT06806163 · 1,350 participants · NA
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
- NCT05245227 · 1,358 participants · Phase 3
Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia